KMS Medisurgi Board of Directors
Get the latest insights into the leadership at KMS Medisurgi. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Siddharth Gaurang Kanakia | Chairman & Managing Director |
| Ms. Monali Gaurang Kanakia | Executive Director |
| Mr. Rohan Devang Kanakia | Non Exe.Non Ind.Director |
| Mr. Gaurang Prataprai Kanakia | Non Exe.Non Ind.Director |
| Mr. Hardik Rajnikant Bhatt | Independent Director |
| Mr. Kamlesh Chunilal Rajani | Independent Director |
| Mr. Pratik Pravin Tarpara | Independent Director |
KMS Medisurgi Share price
KMSMEDI
126.5
0.00 (0.00%)Last updated on 4 Sep, 2025 | 16:00 IST
BUYSELL
Today's High
00
Today's Low
00
52 Week Low
120.50
52 Week High
132.30
The current prices are delayed, login to your account for live prices
LoginKMS Medisurgi FAQs
The board at KMS Medisurgi consists of experienced professionals, including Mr. Siddharth Gaurang Kanakia , Ms. Monali Gaurang Kanakia , and others, overseeing the company’s strategic and corporate governance.
Directors at KMS Medisurgi are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Siddharth Gaurang Kanakia is the current chairman at KMS Medisurgi.
Executive directors at KMS Medisurgi are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, KMS Medisurgi adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At KMS Medisurgi, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.